Cargando…
803. Overcoming β-Lactam Resistance in Mycobacterium abscessus
BACKGROUND: Mycobacterium abscessus (Mab) is an environmentally acquired nontuberculous mycobacterium (NTM) that causes severe pulmonary infections in patients with chronic lung disease, such as cystic fibrosis (CF). The incidence of drug-resistant Mab infections in CF patients in the United States...
Autores principales: | Story-Roller, Elizabeth, Lamichhane, Gyanu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6253610/ http://dx.doi.org/10.1093/ofid/ofy210.810 |
Ejemplares similares
-
Mycobacterium abscessus and β-Lactams: Emerging Insights and Potential Opportunities
por: Story-Roller, Elizabeth, et al.
Publicado: (2018) -
T405, a New Penem, Exhibits In Vivo Efficacy against M. abscessus and Synergy with β-Lactams Imipenem and Cefditoren
por: Rimal, Binayak, et al.
Publicado: (2022) -
Compromised longevity due to Mycobacterium abscessus pulmonary disease in lungs scarred by tuberculosis
por: Singh, Urvashi B., et al.
Publicado: (2019) -
A mouse model of pulmonary Mycobacteroides abscessus infection
por: Maggioncalda, Emily C., et al.
Publicado: (2020) -
1385. Mechanism-Based, In Vitro Inhibition of Mycobacterium abscessus: Assessing β-Lactam Therapy
por: Dousa, Khalid M, et al.
Publicado: (2019)